scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1083854045 |
P356 | DOI | 10.1186/S12974-017-0812-Y |
P932 | PMC publication ID | 5319028 |
P698 | PubMed publication ID | 28222766 |
P50 | author | Maria Donata Benedetti | Q51041139 |
Stefania Rossi | Q55835206 | ||
Marco Pitteri | Q48879573 | ||
P2093 | author name string | Richard Reynolds | |
Francesco Facchiano | |||
Massimiliano Calabrese | |||
Gabriele Farina | |||
Salvatore Monaco | |||
Roberta Magliozzi | |||
Alberto Gajofatto | |||
P2860 | cites work | Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS) | Q22241644 |
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria | Q24605493 | ||
The Ins and Outs of B Cells in Multiple Sclerosis | Q26776542 | ||
A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients | Q48901292 | ||
Gray matter damage predicts the accumulation of disability 13 years later in MS. | Q48935280 | ||
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis | Q48949792 | ||
Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. | Q54626145 | ||
Distinct CSF cytokine/chemokine profiles in atopic myelitis and other causes of myelitis. | Q55239353 | ||
Peripheral B cell depletion and central proinflammatory cytokine reduction following repeated intrathecal administration of rituximab in progressive Multiple Sclerosis | Q61230854 | ||
CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis | Q28244975 | ||
Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis | Q28252596 | ||
MRI correlates of cognitive dysfunction in multiple sclerosis patients. | Q30599649 | ||
Soluble CD163 as a marker of macrophage activity in newly diagnosed patients with multiple sclerosis | Q33700473 | ||
Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis | Q34295012 | ||
Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis | Q34472457 | ||
Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel | Q35364112 | ||
Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies | Q35377133 | ||
Inflammatory cortical demyelination in early multiple sclerosis | Q35764685 | ||
Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs | Q36072414 | ||
Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement | Q36163180 | ||
B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation | Q36485715 | ||
Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status | Q36722852 | ||
Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. | Q37285430 | ||
Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude | Q38083645 | ||
Exploring the origins of grey matter damage in multiple sclerosis. | Q38361889 | ||
The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain. | Q38621895 | ||
Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis. | Q39025444 | ||
Parenchymal accumulation of CD163+ macrophages/microglia in multiple sclerosis brains | Q39511165 | ||
Proteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis | Q40126243 | ||
AN ELECTROPHORETIC STUDY OF THE PROTEIN COMPONENTS IN CEREBROSPINAL FLUID AND THEIR RELATIONSHIP TO THE SERUM PROTEINS. | Q40973713 | ||
Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4. | Q41040137 | ||
A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. | Q42847184 | ||
Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS. | Q43227358 | ||
B cells undergo unique compartmentalized redistribution in multiple sclerosis | Q44463732 | ||
BAFF maintains T-cell survival by inducing OPN expression in B cells | Q44657459 | ||
Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. | Q45191165 | ||
Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats | Q45799560 | ||
Lipid microarrays identify key mediators of autoimmune brain inflammation | Q46845275 | ||
Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. | Q47357498 | ||
Axonal pathology in multiple sclerosis. A historical note | Q48093198 | ||
Cerebrospinal fluid CXCL13 in clinically isolated syndrome patients: Association with oligoclonal IgM bands and prediction of Multiple Sclerosis diagnosis | Q48162212 | ||
Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. | Q48200750 | ||
The Rao's Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population | Q48293543 | ||
Cortical lesion load associates with progression of disability in multiple sclerosis. | Q48336159 | ||
Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma | Q48462130 | ||
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment | Q48701331 | ||
P433 | issue | 1 | |
P921 | main subject | multiple sclerosis | Q8277 |
P304 | page(s) | 40 | |
P577 | publication date | 2017-02-21 | |
P1433 | published in | Journal of Neuroinflammation | Q15716679 |
P1476 | title | Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study | |
P478 | volume | 14 |
Q49686544 | A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation. |
Q98463732 | Advanced MRI features in relapsing multiple sclerosis patients with and without CSF oligoclonal IgG bands |
Q89531252 | Association of intrathecal pleocytosis and IgG synthesis with axonal damage in early MS |
Q33841113 | Differential contribution of immune effector mechanisms to cortical demyelination in multiple sclerosis |
Q64279716 | Differential neuro-immune patterns in two clinically relevant murine models of multiple sclerosis |
Q92106211 | Immunity in Gilles de la Tourette-Syndrome: Results From a Cerebrospinal Fluid Study |
Q90313485 | Increase of CSF inflammatory profile in a case of highly active multiple sclerosis |
Q64266133 | MRI phenotypes in MS: Longitudinal changes and miRNA signatures |
Q89830634 | Oligoclonal IgG antibodies in multiple sclerosis target patient-specific peptides |
Q90479562 | Wide Cytokine Analysis in Cerebrospinal Fluid at Diagnosis Identified CCL-3 as a Possible Prognostic Factor for Multiple Sclerosis |
Search more.